![Jennifer H. Hartt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jennifer H. Hartt
Directeur/Membre du Conseil chez
Jenrin Discovery LLC
Profil
Jennifer H.
Hartt is currently the Director at Jenrin Discovery LLC.
Previously, she worked as the Associate Director at the University of Pennsylvania, Managing Director of Healthcare Investment Group at Ben Franklin Technology Partners, Director at PhenoTech, Inc., and Observer at Invisalert Solutions, Inc. She also worked as a Principal at Drexel University.
Ms. Hartt completed her undergraduate degree at the University of Pennsylvania in 2006.
Postes actifs de Jennifer H. Hartt
| Sociétés | Poste | Début |
|---|---|---|
Jenrin Discovery LLC
 Jenrin Discovery LLC Pharmaceuticals: MajorHealth Technology Develops therapeutics for chronic diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Jennifer H. Hartt
| Sociétés | Poste | Fin |
|---|---|---|
Ben Franklin Technology Partners /Ventures/
 Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Tech Partners invests in companies located in the US. The firm focuses on IT, life sciences and physical sciences. It participates in seed and early-stage capital requirements. | Private Equity Investor | 31/12/2022 |
Invisalert Solutions, Inc.
 Invisalert Solutions, Inc. Packaged SoftwareTechnology Services Develops software based solution for checking patients every fifteen minutes | Corporate Officer/Principal | - |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
PhenoTech, Inc.
 PhenoTech, Inc. BiotechnologyHealth Technology Develops and markets monoclonal antibodies which are used in blood diagnostic and therapeutic applications | Directeur/Membre du Conseil | - |
Formation de Jennifer H. Hartt
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
98
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Jenrin Discovery LLC
Jenrin Discovery LLC Pharmaceuticals: MajorHealth Technology Develops therapeutics for chronic diseases | Health Technology |
Invisalert Solutions, Inc.
Invisalert Solutions, Inc. Packaged SoftwareTechnology Services Develops software based solution for checking patients every fifteen minutes | Technology Services |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drexel University
Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ben Franklin Technology Partners /Ventures/
Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Tech Partners invests in companies located in the US. The firm focuses on IT, life sciences and physical sciences. It participates in seed and early-stage capital requirements. | Finance |
PhenoTech, Inc.
PhenoTech, Inc. BiotechnologyHealth Technology Develops and markets monoclonal antibodies which are used in blood diagnostic and therapeutic applications | Health Technology |
